| Ticker Details |
Regeneron Pharmaceuticals, Inc.
Regeneron Pharmaceuticals Inc is an integrated biopharmaceutical company. It discovers, invents, develops, manufactures, and commercializes medicines for the treatment of serious medical conditions.
|
| IPO Date: |
April 2, 1991 |
| Sector: |
Healthcare |
| Industry: |
Biotech |
| Market Cap: |
$81.18B |
| Activated in VL: |
True |
| Average Daily Range |
| Avg Daily Range: |
$4.41 | 1.79%
|
| Avg Daily Range (30 D): |
$10.40 | 1.36%
|
| Avg Daily Range (90 D): |
$10.29 | 1.35%
|
| Institutional Daily Volume |
| Avg Daily Volume: |
.67M |
| Avg Daily Volume (30 D): |
.45M |
| Avg Daily Volume (90 D): |
.58M |
| Trade Size |
| Avg Trade Size (Sh.): |
60 |
| Avg Trade Size (Sh.) (30 D): |
17 |
| Avg Trade Size (Sh.) (90 D): |
19 |
| Institutional Trades |
| Total Institutional Trades: |
11,678 |
| Avg Institutional Trade: |
$19.54M |
| Avg Institutional Trade (30 D): |
$59.11M |
| Avg Institutional Trade (90 D): |
$54.51M |
| Avg Institutional Trade Volume: |
.05M |
| Avg Institutional Trades (Per Day): |
2 |
| Market Closing Trades |
| Avg Closing Trade: |
$38.42M |
| Avg Closing Trade (30 D): |
$93.74M |
| Avg Closing Trade (90 D): |
$99.96M |
| Avg Closing Volume: |
75.74K |
|
|
| Financials |
| |
TTM |
Q4 2025 |
FY 2025 |
|
Basic EPS
|
$43.07
|
$8.24
|
$43.07
|
|
Diluted EPS
|
$41.48
|
$7.87
|
$41.48
|
|
Revenue
|
$14.34B
|
$3.88B
|
$14.34B
|
|
Gross Profit
|
|
|
|
|
Net Income / Loss
|
$4.5B
|
$844.6M
|
$4.5B
|
|
Operating Income / Loss
|
$3.58B
|
$879.9M
|
$3.58B
|
|
Cost of Revenue
|
|
|
|
|
Net Cash Flow
|
$634.7M
|
$610.6M
|
$634.7M
|
|
PE Ratio
|
18.07
|
|
|
|
|
|
